Cargando…

Pancreatic follicular lymphoma: a report of two cases and literature review

Primary pancreatic lymphomas are extremely rare, accounting for 0.1–0.5% of malignant lymphomas and about 0.2% of primary pancreatic tumors. They occur most commonly in the pancreatic head of elderly males, with diffuse large B-cell lymphoma being the most common subtype. Primary pancreatic follicul...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Takeshi, Sasaki, Takashi, Nishimura, Noriko, Takamatsu, Manabu, Mori, Chinatsu, Mie, Takafumi, Furukawa, Takaaki, Yamada, Yuto, Takeda, Tsuyoshi, Kasuga, Akiyoshi, Matsuyama, Masato, Ozaka, Masato, Maruyama, Dai, Sasahira, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395385/
https://www.ncbi.nlm.nih.gov/pubmed/34453279
http://dx.doi.org/10.1007/s12328-021-01507-2
Descripción
Sumario:Primary pancreatic lymphomas are extremely rare, accounting for 0.1–0.5% of malignant lymphomas and about 0.2% of primary pancreatic tumors. They occur most commonly in the pancreatic head of elderly males, with diffuse large B-cell lymphoma being the most common subtype. Primary pancreatic follicular lymphoma is the most commonly reported primary pancreatic indolent lymphoma, accounting for 9–14% of primary pancreatic lymphomas. We report two cases of primary pancreatic follicular lymphoma treated with obinutuzumab, a second-generation humanized anti-CD20 monoclonal antibody, and bendamustine. One was diagnosed by endoscopic ultrasound-guided fine-needle aspiration, while the other required laparoscopic lymph node sampling to reach a diagnosis. Both achieved complete response with induction therapy and opted for maintenance therapy with obinutuzumab. We also conducted a literature review of primary pancreatic follicular lymphoma cases reported over the last 30 years.